Data from ARF Regulates the Stability of p16 Protein Via REGγ-Dependent Proteasome Degradation

Takashi Kobayashi,Jingqiang Wang,Hikmat Al-Ahmadie,Cory Abate-Shen
DOI: https://doi.org/10.1158/1541-7786.c.6539257
2023-01-01
Abstract:<div>Abstract<p>The cell-cycle regulatory gene <i>INK4A-ARF (CDKN2A)</i> has two alternative transcripts that produce entirely different proteins, namely p14<sup>ARF</sup> and p16, which have complementary functions as regulators of p53 and pRB tumor suppressor pathways, respectively. The unusual organization of <i>INK4A-ARF</i> has long led to speculation of a need for coordinated regulation of p14<sup>ARF</sup> and p16. We now show that p14<sup>ARF</sup> (ARF) regulates the stability of p16 protein in human cancer cell lines, as well as in mouse embryonic fibroblasts (MEFs). In particular, ARF promotes rapid degradation of p16 protein, which is mediated by the proteasome and, more specifically, by interaction of ARF with one of its subunits, REGγ. Furthermore, this ARF-dependent destabilization of p16 can be abrogated by knockdown of <i>REGγ</i> or by pharmacologic blockade of its nuclear export. Thus, our findings have uncovered a novel crosstalk of 2 key tumor suppressors mediated by a REGγ-dependent mechanism. The ability of ARF to control p16 stability may influence cell-cycle function.</p><p><b>Implications:</b> The ability of ARF to control p16 stability may influence cell cycle function.</p><p><b>Visual Overview:</b> <a href="http://mcr.aacrjournals.org/content/11/8/828/F1.large.jpg" target="_blank">http://mcr.aacrjournals.org/content/11/8/828/F1.large.jpg</a>. <i>Mol Cancer Res; 11(8); 828–33. ©2013 AACR</i>.</p></div>
What problem does this paper attempt to address?